Expression of WISP3 and RhoC Genes at mRNA and Protein Levels in Inflammatory and Noninflammatory Breast Cancer in Tunisian Patients

REFERENCES

• Chevallier, B.; Asselain, B.; Kunlin, A.; Veyret, C.; Bastit, P.; Graic, Y. Inflammatory breast cancer: determination of prognostic factors by univariate and multivariate analysis. Cancer 1987, 60, 897–902.
   PubMed Web of Science ®Google Scholar
• Boussen, H.; Bouzaine, H.; Ben Hassouna, J.; Gammoudi, A.; Benna, F.; Rahal, K. Inflammatory breast cancer in Tunisia: reassessment of incidence and linicopathological features. Seminars Oncologie 2008, 35, 17–24.
   PubMed Web of Science ®Google Scholar
• Chang, S.; Parker, S.L.; Pham, T.; Buzdar, A.U.; Hursting, S.D. Inflammatory breast carcinoma: incidence and survival. The surveillance, epidemiology, and end results program of the National Cancer Institute, 1975–1992. Cancer 1998, 82, 2366–2372.
   PubMed Web of Science ®Google Scholar
• Van dA, I.; Van Laere, S.J.; Van den Eynden, G.G.; Benoy, I.; van Dam, P.; Colpaert, C.G.; Fox, S.B.; Turley, H.; Harris, A.L.; Van Marck, E.A.; Vermeulen, P.B.; Dirix, L.Y. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res 2004, 10, 7965–7971.
   PubMed Web of Science ®Google Scholar
• Cristofanilli, M.; Buzdar, A.U.; Hortobagyi, G.N. Update on the management of inflammatory breast cancer. Oncologist 2003, 8, 141–148.
   PubMed Web of Science ®Google Scholar
• Jaiyesimi, I.A.; Buzdar, A.U.; Hortobagyi, G. Inflammatory breast cancer: a review. J Clin Oncol 1992, 10, 1014–1024.
   PubMed Web of Science ®Google Scholar
• Swain, S.M.; Sorace, R.A.; Bagley, C.S.; Danforth, D.N. Jr.; Bader, J.; Wesley, M.N.; Steinberg, S.M.; Lippman, M.E. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 1987, 47, 3889–3894.
   PubMed Web of Science ®Google Scholar
• Levine, P.H.; Steinhorn, S.C.; Ries, L.G.; Aron, J.L. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst 1985, 74, 291–297.
   PubMed Web of Science ®Google Scholar
• Levine, P.H.; Pogo, B.G.; Klouj, A.; Coronel, S.; Woodson, K.; Melana, S.M.; Mourali, N.; Holland, J.F. Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer 2004, 101, 721–726.
   PubMed Web of Science ®Google Scholar
• Mourali, N.; Levine, P.H.; Tabanne, F.; Belhassen, S.; Bahi, J.; Bennaceur, M.; Herberman, R.B. Rapidly progressing breast cancer (poussee evolutive) in Tunisia: studies on delayed hypersensitivity. Int J Cancer 1978, 22, 1–3.
   PubMed Web of Science ®Google Scholar
• Charafe-Jauffret, E.; Tarpin, C.; Bardou, V.J.; Bertucci, F.; Ginestier, C.; Braud, A.C.; Puig, B.; Geneix, J.; Hassoun, J.; Birnbaum, D.; Jacquemier, J.; Viens, P. Immunophenotypic analysis of inflammatory breast cancers: identification of an inflammatory signature. J Pathol 2004, 202, 265–273.
   PubMed Web of Science ®Google Scholar
• Charafe-Jauffret, E.; Mrad, K.; Intidhar, L.S.; Ben Hamida, A.; Ben Romdhane, K.; Ben Abdallah, M.; Ginestier, C.; Esterni, B.; Birnbaum, D.; Ben Ayed, F.; Xerri, L.; Viens, P.; Mezlini, A.; Jacquemier, J. Inflammatory breast cancers in Tunisia and France show similar immunophenotypes. Breast 2007, 16, 352–358.
   PubMed Web of Science ®Google Scholar
• Kleer, C.G.; Zhang, Y.; Pan, Q.; Gallagher, G.; Wu, M.; Wu, Z.F.; Merajver, S.D. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Res 2004, 6(2), 110–115.
   PubMed Web of Science ®Google Scholar
• Kleer, C.G.; van Golen, K.L.; Zhang, Y.; Wu, Z.F.; Rubin, M.A.; Merajver, S.D. Characterization of RhoC expression in benign and malignant breast disease. Am J Pathol 2002, 160, 579–584.
   PubMed Web of Science ®Google Scholar
• Kimura, K.; Ito, M.; Amano, M.; Chihara, K.; Fukata, Y.; Nakafuku, M.; Yamamori, B.; Feng, J.; Nakano, T.; Okawa, K.; Iwamatsu, A.; Kaibuchi, K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996, 273, 245–248.
   PubMed Web of Science ®Google Scholar
• Nobes, C.D.; Hall, A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81, 53–62.
   PubMed Web of Science ®Google Scholar
• Jaffe, A.B.; Hall, A. RHO GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005, 21, 247–269.
   PubMed Web of Science ®Google Scholar
• Watanabe, T.; Noritake, J.; Kaibuchi, K. Regulation of microtubules in cell migration. Trends Cell Biol 2005, 15, 76–83.
   PubMed Web of Science ®Google Scholar
• Wheeler, A.P.; Ridley, A.J. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004, 301, 43–49.
   PubMed Web of Science ®Google Scholar
• Ridley, A.J. Rho proteins and cancer. Breast Cancer Res Treat 2004, 84, 13–19.
   PubMedGoogle Scholar
• Wu, M.; Wu, Z.F.; Kumar-Sinha, C.; Chinnaiyan, A.; Merajver, S.D. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res Treat 2004, 84, 3–12.
   PubMed Web of Science ®Google Scholar
• Perbal, B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 2001, 54, 57–79.
   PubMedGoogle Scholar
• Hurvitz, J.R.; Suwairi, W.M.; Van Hul, W.; El-Shanti, H.; Superti-Furga, A.; Roudier, J.; Holderbaum, D.; Pauli, R.M.; Herd, J.K.; Van Hul, E.V.; Rezai- Delui, H.; Legius, E.; Le Merrer, M.; Al-Alami, J.; Bahabri, S.A.; Warman, M.L. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 1999, 23, 94–98.
   PubMed Web of Science ®Google Scholar
• Moussad, E.E.; Brigstock, D.R. Connective tissue growth factor: what's in a name? Mol Genet Metab 2000, 71, 276–292.
   PubMed Web of Science ®Google Scholar
• Bringstock, D. The CCN family: a new stimulus package. J Endocrinol 2003, 178, 169–175.
   PubMed Web of Science ®Google Scholar
• Sen, M.; Cheng, Y-H.; Goldring, M.B.; Lotz, M.K.; Carson, D.A. WISP-3 dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum 2004, 50, 488–497.
   PubMed Web of Science ®Google Scholar
• Davis, L.; Chen, Y.; Sen, M. WISP-3 functions as a ligand and promotes superoxide dismutase activity. BBRC 2006, 342, 259–265.
   PubMed Web of Science ®Google Scholar
• Kleer, C.G.; Zhang, Y.; Pan, Q.; van Golen, K.L.; Wu, Z.F.; Livant, D.; Merajver, S.D. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 2002, 21, 3172–3180.
   PubMed Web of Science ®Google Scholar
• Lamb, R.; Thomson, W.; Ogilvie, E.; Donn, R. Wnt-1 inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis. Arthritis Rheum 2005, 52, 3548–3553.
   PubMed Web of Science ®Google Scholar
• van Golen, K.L.; Davies, S.; Wu, Z.F.; Wang, Y.; Bucana, C.D.; Root, H.; Chandrasekharappa, S.; Strawderman, M.; Ethier, S.P.; Merajver, S.D. A novel putative low affinity insulin-like growth factor binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 1999, 5, 2511–2519.
   PubMed Web of Science ®Google Scholar
• Cervello, M.; Giannitrapani, L.; Labbozzetta, M.; Notarbartolo, M.; D'Alessandro, N.; Lampiasi, N.; Azzolina, A.; Montalto, G. Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. Ann N Y Acad Sci 2004, 1028, 432–439.
   PubMed Web of Science ®Google Scholar
• Pennica, D.; Swanson, T.A.; Welsh, J.W.; Roy, M.A.; Lawrence, D.A.; Lee, J.; Brush, J.; Taneyhill, L.A.; Deuel, B.; Lew, M.; Watanabe, C.; Cohen, R.L.; Melhem, M.F.; Finley, G.G.; Quirke, P.; Goddard, A.D.; Hillan, K.J.; Gurney, A.L.; Botstein, D.; Levine, A.J. WISP genes are members of the connective tissue growth factor family that are upregulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 1998, 95, 14717–14722.
   PubMed Web of Science ®Google Scholar
• van Golen, K.L.; Wu, Z.F.; Qiao, X.T.; Bao, L.W.; Mearajver, S.D. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 2000, 60, 5832–5838.
   PubMed Web of Science ®Google Scholar
• Van den Eynden, G.G.; Van der Auwera, I.; Van Laere, S.; Colpaert, C.G.; van Dam, P.; Merajver, S.; Kleer, C.G.; Harris, A.L.; Van Marck, E.A.; Dirix, L.Y.; Vermeulen, P.B. Validation of a tissue microarray to study differential protein expression in inflammatory and noninflammatory breast cancer. Breast Cancer Res Treat 2004, 85, 13–22.
   PubMed Web of Science ®Google Scholar
• Kamai, T.; Tsujii, T.; Arai, K.; Takagi, K.; Asami, H.; Ito, Y.; Oshima, H. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 2003, 9(7), 2632–2641.
   PubMed Web of Science ®Google Scholar
• Horiuchi, A.; Itoh, K.; Shimizu, M.; Nakai, I.; Yamazaki, T.; Kimura, K.; Suzuki, A.; Shiozawa, I.; Ueda, N.; Konishi, I. Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach. Gynecol Oncol 2003, 88(3), 309–317.
   PubMed Web of Science ®Google Scholar
• Suwa, H.; Oshio, G.; Imamura, T.; Watanabe, G.; Arii, S.; Imamura, M.; Hiai, H.; Fukumoto, M. Overexpression of the RhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 1998, 77, 147–152.
   PubMedGoogle Scholar
• Clark, E.A.; Golub, T.R.; Lander, E.S.; Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2002, 406, 532–535.
   Web of Science ®Google Scholar
• Sahai, E.; Marshall, C.J. ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat Cell Biol 2002, 4, 408–415.
   PubMedGoogle Scholar
• Sawaki, M.; Ito, Y.; Akiyama, F.; Tokudome, N.; Horii, R.; Mizunuma, N.; Takahashi, S.; Horikoshi, N.; Imai, T.; Nakao, A.; Kasumi, F.; Sakamoto, G.; Hatake, K. High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer. Breast Cancer 2006, 13, 172–178.
   PubMedGoogle Scholar
• Bertheau, I.; Plassa, F.; Espié, M.; Turpin, E.; de Roquancourt, A.; Marty, M.; Lerebours, F.; Beuzard, Y.; Janin, A.; de Thé, H. Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy. Lancet 2002, 360, 852–854.
   PubMed Web of Science ®Google Scholar